首页> 外文会议>IEEE-EMBS Conference on Biomedical Engineering and Sciences >Application of Machine Learning Techniques for study of drug interactions using clinical parameters for Creutzfeldt-Jakob disease
【24h】

Application of Machine Learning Techniques for study of drug interactions using clinical parameters for Creutzfeldt-Jakob disease

机译:机器学习技术在克雷兹菲尔特 - 雅各布疾病中使用临床参数研究药物相互作用研究

获取原文

摘要

Drug discovery is one of the emerging areas of research, in which the association between drugs and diseases are studied to infer the effect of drug induced to patients having similar clinical parameters. As per the regulations of statutory organizations, clinical trials are to be made after the drug proceeds to substantial improvement under variety of guidelines. In some diseases like Creutzfeldt-Jakob disease which is a degenerative brain disorder progresses more rapidly than Alzheimer's disease, it is very much indeed to study the association between drug and its impact over clinical parameter. Even though CJD is a rare occurring disease in young age, but it is more progressing in the elders with asymptotically that leads to dementia and ultimately death with a very short living span of less than a year. Since the clinical parameters to the disease are very less, computational algorithms can be applied on the available clinical parameters with drug labels. Due to the advent of simple, yet powerful machine learning algorithms the modeling of the drug interactions with varying clinical parameters became quite imperative. In this work, the application of various machine learning algorithms with parameter tuning facilities were analyzed to facilitate the study of the drug over clinical parameters. The study ends up in developing a machine learning model, which will suggest the drugs when clinical parameters are inputted. This work analyses different machine learning algorithms such as Logistic Regression, KNN, DTC, RFC, SVC, XG Boost with an ability to tune the parameter with relevance to the available dataset. The designed models are validated against k-fold stratified cross-validation to construe the better classification model. The results show that, Random forest classifier outperform with XG Boost classification algorithm with a mean accuracy precision of 98.39% while the later provides a mean accuracy precision of 97.96%.
机译:药物发现是新兴的研究领域之一,其中研究了药物和疾病之间的关联,以推断出诱导的药物对具有相似临床参数的患者的作用。根据法定组织的规定,临床试验将在药物在各种准则下进行大量改善后进行。在像克雷托茨菲尔特 - 雅各的疾病这样的疾病中,这是一种退行性脑病的疾病比阿尔茨海默病更快地进展,它确实要研究药物之间的关联及其对临床参数的影响。尽管CJD在年轻时是一种罕见的发生疾病,但它在渐近的长度中越来越进入,导致痴呆症,最终死亡,生活跨度少于一年。由于对疾病的临床参数非常较小,因此可以对具有药物标记的可用临床参数应用计算算法。由于简单而强大的机器学习算法的出现,与不同临床参数的药物相互作用的建模变得非常势在必行。在这项工作中,分析了各种机器学习算法与参数调整设施的应用,以促进药物在临床参数上的研究。该研究最终开发了机器学习模型,这将在输入临床参数时提出药物。这项工作分析了不同的机器学习算法,如逻辑回归,KNN,DTC,RFC,SVC,XG升压,能够调整与可用数据集相关的参数。设计的模型针对K折叠分层交叉验证验证,以解释更好的分类模型。结果表明,随机森林分类器优于XG升压分类算法,平均精度精度为98.39%,而后者提供了97.96%的平均精度精度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号